A Sanfilippo

466 total citations
28 papers, 354 citations indexed

About

A Sanfilippo is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, A Sanfilippo has authored 28 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Organic Chemistry and 7 papers in Pharmacology. Recurrent topics in A Sanfilippo's work include Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Chemical Synthesis and Analysis (4 papers) and Tuberculosis Research and Epidemiology (4 papers). A Sanfilippo is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Chemical Synthesis and Analysis (4 papers) and Tuberculosis Research and Epidemiology (4 papers). A Sanfilippo collaborates with scholars based in Italy and Switzerland. A Sanfilippo's co-authors include D. Ungheri, M Ghione, Daniela Jabés, Giuseppe Cassinelli, Giovanni Franceschi, Alberto Gasco, A. Grein, Federico Arcamone, P. Orezzi and R. CALVINO and has published in prestigious journals such as Annals of the New York Academy of Sciences, Antimicrobial Agents and Chemotherapy and Cellular and Molecular Life Sciences.

In The Last Decade

A Sanfilippo

28 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A Sanfilippo Italy	10	134	103	101	101	76	28	354
N. Maggi	6	114 0.9×	74 0.7×	70 0.7×	96 1.0×	99 1.3×	13	326
F Lund Denmark	6	115 0.9×	135 1.3×	92 0.9×	54 0.5×	39 0.5×	10	344
M.N. Gwynn United Kingdom	7	147 1.1×	115 1.1×	69 0.7×	42 0.4×	132 1.7×	8	361
Kenneth DenBleyker United States	9	138 1.0×	99 1.0×	144 1.4×	46 0.5×	65 0.9×	11	343
Makoto Kida Japan	13	240 1.8×	164 1.6×	63 0.6×	40 0.4×	36 0.5×	36	459
Kenji Namba Japan	10	161 1.2×	70 0.7×	66 0.7×	105 1.0×	112 1.5×	18	446
F. Kradolfer Switzerland	12	215 1.6×	221 2.1×	222 2.2×	51 0.5×	43 0.6×	41	589
T Matsubara Japan	11	156 1.2×	197 1.9×	51 0.5×	30 0.3×	78 1.0×	32	450
Constantin Agouridas France	8	283 2.1×	102 1.0×	194 1.9×	220 2.2×	117 1.5×	8	546
E. Böhni Switzerland	11	106 0.8×	85 0.8×	61 0.6×	77 0.8×	37 0.5×	26	285

Countries citing papers authored by A Sanfilippo

Since Specialization

Citations

This map shows the geographic impact of A Sanfilippo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Sanfilippo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Sanfilippo more than expected).

Fields of papers citing papers by A Sanfilippo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Sanfilippo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Sanfilippo. The network helps show where A Sanfilippo may publish in the future.

Co-authorship network of co-authors of A Sanfilippo

This figure shows the co-authorship network connecting the top 25 collaborators of A Sanfilippo. A scholar is included among the top collaborators of A Sanfilippo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Sanfilippo. A Sanfilippo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bellone, Marta, et al.. (2022). POSC113 Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in the Treatment of HER2-Positive Breast Cancer (HER2+ BC) Patients in Italy: A Budget Impact Analysis. Value in Health. 25(1). S109–S109. 1 indexed citations

Panella, Massimiliano, et al.. (1987). Ovarian carcinoma in adolescents.. PubMed. 14(3-4). 167–8. 1 indexed citations

Ungheri, D., et al.. (1985). Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis.. PubMed. 31(3). 211–4. 8 indexed citations

Ungheri, D., et al.. (1984). [Activity of the ansamycins LM 427 and FCE 22250 on atypical mycobacteria in vitro].. PubMed. 30(2-3). 97–100. 1 indexed citations

Franceschi, Giovanni, et al.. (1984). Novel rifamycins. IV. 3-Aminomethylazinomethylrifamycins, a new class of rifamycins, endowed with remarkable antibacterial activity.. The Journal of Antibiotics. 37(10). 1209–1212. 3 indexed citations

Ungheri, D., et al.. (1983). LM 427,a new spiropiperidylrifamycin: In vitro and in vivo studies.. The Journal of Antibiotics. 36(11). 1502–1506. 57 indexed citations

Franceschi, Giovanni, et al.. (1983). Novel rifamycins. III Synthesis and antibacterial activity of 3-amidino- and of 4-aminoimidazolo(4,5-c)rifamycin derivatives.. The Journal of Antibiotics. 36(11). 1495–1501. 2 indexed citations

Sanfilippo, A, Daniela Jabés, Giovanni Franceschi, et al.. (1982). Biological activity of (5R,6S,8R)-6-.ALPHA.-hydroxyethyl-2-acetoxymethyl-2-penem-3-carboxylate.. The Journal of Antibiotics. 35(9). 1248–1251. 8 indexed citations

CALVINO, R., et al.. (1980). Antimicrobial properties of some furazan and furoxan derivatives.. 15(5). 485–487. 24 indexed citations

10.

Sanfilippo, A, et al.. (1980). Biological activity of a new class of rifamycins Spiro-piperidyl-rifamycins.. The Journal of Antibiotics. 33(10). 1193–1198. 38 indexed citations

11.

Sanfilippo, A, et al.. (1977). ChemInform Abstract: SYNTHESIS, ANTIBACTERIAL AND ANTIFUNGAL ACTIVITY OF PHENYLAZOXYCYANIDE DERIVATIVES. Chemischer Informationsdienst. 8(22). 2 indexed citations

12.

Fioretti, V., et al.. (1975). Antiviral Activity of a Pyrazino-Pyrazine Derivative. Chemotherapy. 21(3-4). 221–230. 3 indexed citations

13.

Sanfilippo, A, et al.. (1974). Antibacterial activity of aminosidine and of beta-lactamic antibiotics.. PubMed. 29(1). 21–6. 3 indexed citations

14.

Sanfilippo, A, et al.. (1973). New Approach to the Evaluation of Antibacterial Activity of Aminosidine. Chemotherapy. 18(5). 297–303. 4 indexed citations

15.

Sanfilippo, A, et al.. (1971). Immunodepressive activity of adriamycin in experimental infection of the mouse withNippostrongylus brasiliensis. Cellular and Molecular Life Sciences. 27(7). 841–842. 3 indexed citations

16.

Sanfilippo, A, et al.. (1968). An Experimental Model for the Study of the Antibacterial Activity of the Sulfonamides. Chemotherapy. 13(1). 54–60. 17 indexed citations

17.

Ghione, M, et al.. (1967). Research on Factors Influencing Experimental Chemotherapy Tests in Trachoma. American Journal of Ophthalmology. 63(5). 1573–1577. 2 indexed citations

18.

Cassinelli, Giuseppe, et al.. (1967). New antibiotics produced by streptoverticillium orinoci, n. sp.. Archives of Microbiology. 55(4). 358–368. 34 indexed citations

19.

Sanfilippo, A, et al.. (1966). Activity of Distamycin A on the Induction of Adaptive Enzymes in Escherichia coli. Journal of General Microbiology. 43(3). 369–374. 26 indexed citations

20.

Ghione, M, et al.. (1963). Selective inhibition of the multiplication of phage T1 inE. coli K12. Cellular and Molecular Life Sciences. 19(3). 134–136. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact